Improvements in bone seen with anti-sclerostin antibody treatments in experimental models Oct. 1, 2009
Hib-MenCY-TT candidate vaccine is immunogenic and well tolerated as 4th dose in infants Sep. 30, 2009
Antitumor effect of TH-302 plus gemcitabine, docetaxel or pemetrexed seen in phase Ib trial Sep. 30, 2009
RSS